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ABSTRACT
Diabetic individuals have an increased risk for developing cardiovascular
disease due to stiffening of the left ventricle, which is thought to occur, in
part, by increased AGE/RAGE signaling inducing fibroblast
differentiation. Advanced glycation end products (AGEs) accumulate
within the body over time, and under hyperglycemic conditions, the
formation and accumulation of AGEs is accelerated. AGEs exert their
effect by binding to their receptor (RAGE) and can induce myofibroblast
differentiation, leading to increased cell migration. Previous studies have
focused on fibroblast migration during wound healing, in which diabetics
have impaired fibroblast migration compared to healthy individuals.
However, the impact of diabetic conditions as well as AGE/RAGE
signaling has not been extensively studied in cardiac fibroblasts.
Therefore, the goal of this study was to determine how the AGE/RAGE
signaling pathway impacts cell migration in non-diabetic and diabetic
cardiac fibroblasts. Cardiac fibroblasts were isolated from non-diabetic
and diabetic mice with and without functional RAGE and used to perform
a migration assay. Cardiac fibroblasts were plated on plastic, nondiabetic, or diabetic collagen, and when confluency was reached, a line
of migration was generated by scratching the plate and followed by
treatment with pharmacological agents that modify AGE/RAGE signaling.
Diabetic fibroblasts displayed an increase in migration compared to nondiabetic fibroblasts whereas inhibiting the AGE/RAGE signaling pathway
resulted in a significant increase in migration. The results indicate that
the AGE/RAGE signaling cascade causes a decrease in cardiac
fibroblast migration and altering the pathway will produce alterations in
cardiac fibroblast migration.
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EXPERIMENTAL DESIGN &
METHODS
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Mice: Diabetic mice (db) are
homozygous for leptin receptor
mutation, non-diabetic mice
(non-db) are heterozygous.
Transgenic mice lacking an
active form of RAGE (non-db
RKO) were used as well as
Rap1a knockout mice and their
control, Rap1a WT.

Figure 1: The presence of RAGE signaling negatively impacts cardiac
fibroblast migration. Cardiac fibroblasts were isolated from (A ) non-diabetic
with and without RAGE mice, (B) diabetic with and without RAGE mice, and (C)
Rap1a wildtype (WT) and knockout (KO) mice. (D-F) Fibroblasts were plated onto
plastic cell culture dishes, scratched (0hr) and assessed for cell migration after 24
hours. Cells were stained with Coomassie for visualization with the red lines
depicting scratched area (40X and scale bar = 200µm). Number of migrated cells
were normalized to percent scratched area and plotted as mean + SEM (n=7-13).
Student’s t-test used to determine significance.

Figure 4: Cardiac fibroblasts display
increased migration with decreased
RAGE signaling on diabetic collagen.
A) Non-diabetic, B) diabetic, C) nondiabetic RKO, D) diabetic RKO, E)
Rap1a WT, and F) Rap1a KO cardiac
fibroblasts plated on diabetic collagen
were treated with U0126 (ERK inhibitor;
5µM) and ps PKC-ζ (pseudosubstrate
PKC-ζ inhibitor; 1µg/mL). Inhibition of
AGE/RAGE signaling, in RAGE signaling
competent fibroblasts, led to an increase
in migration. No changes in migration
were noted in RKO fibroblasts which
indicated PKC and ERK inhibition does
not impact migration independently of
RAGE signaling. Data represents mean
+ SEM with a n = 10-13 for control and n
= 3-9 for treatments. A one-way ANOVA
and a Dunnett’s post hoc determined
significance (* p<0.05, ** p<0.01,
***p<0.001).
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Migration Assay& Analysis: Used a 48 well
plate with 2-3 replicates per treatment

Fibroblast Isolation: Cardiac
fibroblasts were isolated (2-3
mice per isolation) and
maintained in DMEM containing
15% FBS.

Figure 2: Collagen isolated from diabetic mouse tails have significantly more
CMLs and AGEs compared to non-diabetic collagen. A) Immunofluorescence
(100X; scale bar = 50 µm) images for carboxymethyl lysine (CML) and advanced
glycation end products (AGEs) in non-diabetic collagen and diabetic collagen. B)
Graph depicting semi-quantification of CML and AGEs present in non-diabetic and
diabetic collagen. A two-way ANOVA followed by a Bonferroni post hoc was used
to determine significance (*p<0.05, ***p<0.001, ****p<0.0001)..

Collagen Isolation: Collagen
was isolated from tails of
diabetic or non-diabetic mice.
Drug Treatment: AGE-BSA
(glycated albumin 0.5mg/ml), ),
U0126 (5µm; inhibitor of ERK),
and PKC-ζ Pseudosubstrate
(1µg/mL; ps-PKC-ζ).
Statistical Analysis: A Student’s t-test, one-way ANOVA, or a two-way ANOVA were
conducted, and ANOVAs were followed by an appropriate post hoc.
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Body Weight (g)
29.05 + 0.37
51.09 + 1.26 ****
32.32 + 0.43 ***
56.61 + 0.70 ****
27.72 + 0.35
27.61 + 0.74

Blood Glucose (mg/dL)
204.7 + 7.30
525.0 + 22.67 ****
213.3 + 4.58
412.7 + 29.44 ****
217.2 + 6.32
172.1 + 6.73

Heart Weight (g)
0.1173 + 0.005
0.1106 + 0.002
0.1184 + 0.002
0.1216 + 0.002
0.1106 + 0.002
0.1085 + 0.005

HYPOTHESIS
Activation of the RAGE cascade alters cardiac fibroblast migration in type II
diabetic mice.

Figure 5: Increased exogenous AGEs in diabetic collagen led to increased fibroblast migration.
Cardiac fibroblasts from A) non-diabetic and diabetic, B) RAGE knockout, and C) Rap1a mice were
plated on diabetic collagen. Fibroblasts were either untreated (control) or treated with AGEs (0.5
mg/mL). The increased migration with AGE treatment is possibly an indirect effect. The AGE treatment
may have caused an increase in “active” fibroblasts, which characteristically migrate more. Cell
migration was normalized to percent scratch area with mean + SEM being depicted on graph. Twoway ANOVA with Sidak’s post hoc determined significance (** p<0.01, n = 5-10).

DISCUSSION

Cytoplasm

Table 1: Morphological data for mice used for in vitro experiments.
Data represents an n-value of 7-12 isolations. One-way ANOVA followed
by Dunnett's post hoc, compared to non-diabetic (***p<0.001,
****p<0.0001)
Non-diabetic (n=47)
Diabetic (n=28)
Non-diabetic RKO (n=41)
Diabetic RKO (n=12)
Rap1a WT (n=34)
Rap1a KO (n=16)
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Figure 3: The elevated levels of AGEs in diabetic collagen did not significantly
impact fibroblast migration. Cardiac fibroblasts isolated from A) non-diabetic and
diabetic, B) non-diabetic and diabetic RAGE knockout, and C) Rap1a WT and KO
mice were plated on either no collagen (results shown in figure 1), non-diabetic
collagen, or diabetic collagen. The number of migrated cells were normalized to
percent scratch area. Data are mean + SEM with a two-way ANOVA and a Sidak’s
post hoc, n = 10-13 (*p<0.05, **p<0.01, ***p<0.001, ****p<0.0001).

• AGE/RAGE signaling modified
cardiac fibroblast migration
• None/Low levels of RAGE
signaling resulted in high levels
of migration
• “Normal” levels of RAGE
signaling resulted in the lowest
amount of fibroblast migration
• High (above normal) levels of
RAGE signaling induced
increase migration which may
be a result of increased
fibroblast “activation”
• Rap1a is involved in fibroblast
migration in conjunction with
RAGE signaling
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